FDA Grants Priority Review Of MDMA-Assisted Therapy For PTSD, Psychedelics Drug Development Company Says: The priority review approval "underscores the urgent unmet need for new innovation in the treatment of PTSD."
https://t.co/1mSaS4l67J
MAPS, a non-profit, spun out a for-profit Lykos Therapeutics for their FDA decision which will be in 2024.
Their earlier results for MDMA (ecstasy) in PTSD are practice changing.
There is a high likelihood of approval and already has breakthrough status.
Upon approval =Psy๐
Incannex Healthcare (@ASX_IHL) has submitted an Investigational New Drug application to the FDA for its product IHL-42X, which combines dronabinol (a synthetic form of THC) & acetazolamide (a carbonic anhydrase inhibitor) to treat obstructive #SleepApnea. https://t.co/QWhzHCgUJJ
$IHL $IXHL Psychedelic-Assisted Therapy at Clarion Clinics ๐๐
Website up & running. Everything you need to know about timings & checking yourself, or someone else in ๐
#Psilocybin#MDMA#PTSD#depression
https://t.co/2wQOqO9enC
$IHL (#ASX#ASXnews) $IXHL (#nasdaq) announcement:
Incannex receives HREC approval for large scale Phase 2 clinical trial assessing IHL-675A for use in treatment of pain and function in Rheumatoid #Arthritis
It follows Phase 1 and animal study observations of IHL-675A substantially reducing inflammatory disease scores to a greater extent than hydroxychloroquine, a common long-standing prescription drug, called #Plaquenil, with a considerable market profile.
Read here: https://t.co/SAO2ZcUkhx
(#FDA #biotech #cbd #thc #medcan)
"Australia is creating an interesting model that could pave the way forward for the rest of the world."
- Dr. Michael Alpert, Psychiatrist at @harvardmed
President Joe Biden has recently begun using a CPAP machine to treat sleep apnea, the White House says, after indentations from straps were seen on both sides of his face Wednesday morning. https://t.co/8yXIjgUWuy